Shares of BioMarin Pharmaceutical Inc. (BMRN) have been trending sideways and a rectangle pattern has emerged. When this pattern is broken, a breakout or breakdown is expected.
BioMarin Pharmaceutical focuses on treatments for serious life-threatening medical conditions. Some of the company’s treatments include Aldurazyme to treat mucopolysaccharidosis I and Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis type 2.
The company is seeing strong demand for Vimizim, which is used to treat Morquio syndrome. One of its newer drugs, Palynziq, is seeing strong commercial uptake in the United States and its rare disease pipeline is growing, with a focus on gene therapy agents.
BMRN had $1.1 billion in cash as of the end of the latest reported quarter, compared with no short-term debt. The company is also highly profitable with a net profit margin of 46.2%. Earnings are up 623% over the past year, but are expected to drop 122.7% in the quarter that just ended in March.
The stock has a low trailing P/E of 17.01, but a very high forward P/E of 238.10. The stock has been trending down this year, but has shown mixed recent momentum.
Take a look at the 1-year chart of BMRN below with the added notations:
Chart of BMRN provided by TradingView
Over the past year, BMRN has formed an important level to watch at the $80 (blue) mark, which has provided both support and resistance multiple times, and a key support level at $72 (green). The stock is currently sitting right between both of those levels now, setting up a trade when either key level is broken.
A long trade could be made on a break back above the $80 resistance level or a trader could enter a short position on a break below $72.
Want to Discover More Great Trades?
I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.
That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to get your copy now!
Have a good trading day!
Christian Tharp, CMT
Want More Great Investing Ideas?
BMRN shares were trading at $76.59 per share on Monday morning, down $0.48 (-0.62%). Year-to-date, BMRN has declined -12.66%, versus a 10.35% rise in the benchmark S&P 500 index during the same period.
About the Author: Christian Tharp
I am an expert stock market coach having helped over 4000 beginner and advanced traders & investors from around the world take control of their financial futures. I also write stock market related articles for the Adam Mesh Trading Group and Yolo Publishing. More...
More Resources for the Stocks in this Article
|Ticker||POWR Rating||Industry Rank||Rank in Industry|
|BMRN||Get Rating||Get Rating||Get Rating|